Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of the Administration of Intravenous Prostaglandin E1 Analog in the Reduction of Mortality and Complications of Patients With COVID-19

NCT04536363 is registered in ClinicalTrials.gov with Alonso Vera Torres as lead sponsor.

NCT NCT04536363
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04536363 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of the Administration of Intravenous Prostaglandin E1 Analog in the Reduction of Mortality and Complications of Patients With COVID-19
Lead sponsor
Alonso Vera Torres
Phase
Phase 2
Overall status
Withdrawn
Start date
December 3, 2020
Completion date
December 3, 2020
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

covid19